Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Novel Magnetic Nanoclusters

Abstract:
While it is not yet an imminent miracle cure for cancer, one day in the future the use of nanoparticles may herald a complete cure for some types of cancer, even those disseminated varieties that are currently difficult to treat.

Novel Magnetic Nanoclusters

August 25, 2005

A University of Leicester research project has received funding of £102,944 from the Engineering and Physical Sciences Research Council (EPSRC) to produce new types of magnetic nanoparticles for use in cancer diagnosis and cancer treatment. The project aims to solve some of the technological problems involved with using magnetic nanoparticles (particles containing just a few hundred atoms) in medical applications, including targeted drug delivery, ultra-high sensitivity detection of tumours and cancer treatments. The research project spans several departments and is being run by Dr Andrew Ellis, Department of Chemistry, Prof. Chris Binns, Department of Physics & Astronomy, and Prof. Kilian Mellon, Department of Cancer Studies and Molecular Medicine.

Prof Binns commented: “At Leicester we are building a unique source of magnetic nanoparticles in which each one has a layered structure of different materials (like a nano-onion). This means that you can design suitable magnetic properties into each nanoparticle to perform a specific task. If the particles are then coated with a final shell of gold they can be attached to biological molecules (such as drugs or antibodies) to perform the diagnosis and therapies described above.”

A novel process for making magnetic nanoparticles will be used, based on layer-by-layer synthesis of nanoparticles inside the supercold, superfluid environment of a liquid helium droplet. This will enable the design of nanoparticles with a degree of control that has hitherto not been possible. The flexibility of the synthetic scheme extends beyond magnetic nanoparticle production, allowing the systematic design of entirely new classes of nanoparticles. Nanotechnology is showing enormous promise as a provider of new tools for probing and manipulating biological systems. Particles with diameters of a few nanometres are sufficiently small that they can readily pass along narrow blood capillaries and may also pass through cell and nuclear membranes.

Prof Binns added: “The main technological problem is that the particles are formed in the gas-phase in ultra-clean vacuum conditions and we have to get them somehow from that environment into a liquid suspension in which they can be attached to biological molecules. Our project is focused on testing ways of doing this and we hope that by the end, in 18 months’ time, we will have magnetic nanoparticles with attached bio-molecules ready for testing in vitro.”

Prof Binns emphasised that this does not mean a cure for cancer within that time framework.

####
Contact:
Prof Chris Binns
Department of Physics and Astronomy
University of Leicester
tel 0116 252 3585
cb12@le.ac.uk


Copyright © University of Leicester

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Possible Futures

A novel method for identifying the body’s ‘noisiest’ networks November 19th, 2014

Researchers discern the shapes of high-order Brownian motions November 17th, 2014

VDMA Electronics Production Equipment: Growth track for 2014 and 2015 confirmed: Business climate survey shows robust industry sector November 14th, 2014

Open Materials Development Will Be Key for HP's Success in 3D Printing: HP can make a big splash in 3D printing, but it needs to shore up technology claims and avoid the temptation of the razor/razor blade business model in order to flourish November 11th, 2014

Investments/IPO's/Splits

Nanometrics Announces Upcoming Investor Events November 19th, 2014

Eight19 secures £1m funding: Investment to develop production technology, and expand commercial activities for organic photovoltaics November 19th, 2014

Arrowhead to Present at Upcoming Conferences November 15th, 2014

Harris & Harris Group Reports Financial Statements as of September 30, 2014 November 11th, 2014

Nanomedicine

New research project supports internationalisation in nano-research: Launch of new “Baltic Sea Network” November 22nd, 2014

Quantum mechanical calculations reveal the hidden states of enzyme active sites November 20th, 2014

Silver Nanoparticles Produced in Iran from Forest Plants Extract November 20th, 2014

Tokyo Institute of Technology research: Protein-engineered cages aid studies of cell functions November 19th, 2014

Materials/Metamaterials

Sustainable Nanotechnologies Project November 20th, 2014

Total Nanofiber Solutions Company FibeRio® Launches The Fiber Engine® FX Series Systems with 10X Increase in Output November 18th, 2014

Nanocomposites Strengthen Bone Implants November 13th, 2014

Production of Magnetic Nanoparticles with New Structures in Iran November 13th, 2014

Announcements

New research project supports internationalisation in nano-research: Launch of new “Baltic Sea Network” November 22nd, 2014

3rd Iran-Proposed Nano Standard Approved by International Standard Organization November 22nd, 2014

NMTI announces breakthrough solutions for HAMR nanoantenna for next-generation ultra-high density magnetic storage November 21st, 2014

Nano Sorbents Able to Remove Pollutions Caused by Oil Derivatives November 20th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE